3,4-Dichloromethylphenidate
| 3,4-DCMP | |
|---|---|
| Molecular structure via molpic based on CDK |
| Rotamer [] | |
|---|---|
| Conformer structure via 3Dmol.js |
| Physical properties [] | |
|---|---|
| Molecular mass | 302.2 g/mol [1] |
| Predicted LogP | 1.5 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C14H17Cl2NO2 [1] |
| IUPAC name | methyl 2-(3,4-dichlorophenyl)-2-piperidin-2-ylacetate [1] |
| SMILES | COC(=O)C(C1CCCCN1)C2=CC(=C(C=C2)Cl)Cl [1] |
| InChI | InChI=1S/C14H17Cl2NO2/c1-19-14(18)13(12-4-2-3-7-17-12)9-5-6-10(15)11(16)8-9/h5-6,8,12-13,17H,2-4,7H2,1H3 [1] |
| InChIKey | JUKMAYKVHWKRKY-UHFFFAOYSA-N [1] |
3,4-Dichloromethylphenidate (also known as Methyl α-(3,4-dichlorophenyl)-2-piperidineacetate, Chembl220195, 3,4-CTMP HCl salt, Schembl15655500, KIA77665, Bdbm50202391, FD31747, 3,4-Dichloromethylphenidate, threo, racemic, NS00018079 or Methyl (3,4-dichlorophenyl)(piperidin-2-yl)acetate) is a
Chemistry
Stereochemistry []
3,4-Dichloromethylphenidate is a racemic mixture of the diastereomers.
Subjective effects []
Experience reports []
There are currently 6 experience reports involving 3,4-dichloromethylphenidate on Erowid:
Legal status []
- Canada: 3,4-Dichloromethylphenidate is a Schedule III substance.
- Germany: 3,4-Dichloromethylphenidate is a Neuer-Psychoaktiver-Stoff under the "Neue-psychoaktive-Stoffe-Gesetz (NpSG)".
- United Kingdom: 3,4-Dichloromethylphenidate is a Class B substance.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 44418862, 1400742-68-8. Accessed May 8, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/44418862